Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids.
about
Pharmacotherapy in the management of asthma in the elderly: a review of clinical studiesInhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology.LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly.Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid MonotherapyThe inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.Bone mineral density and fracture risk with long-term use of inhaled corticosteroids in patients with asthma: systematic review and meta-analysis.Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study.The Skeletal Effects of Inhaled Glucocorticoids.Long-term therapy in COPD: any evidence of adverse effect on bone?Inhaled corticosteroids for asthma: on-demand or continuous use.Meta-review: adverse effects of inhaled corticosteroids relevant to older patients.Safety considerations of inhaled corticosteroids in the elderly.Efficacy and Safety of Indacaterol/Glycopyrronium (IND/GLY) Versus Salmeterol/Fluticasone in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: The Chinese Cohort from the LANTERN Study.Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects.
P2860
Q26769046-9D9ED59F-D65E-4A4D-A063-84E2615DC74BQ34888769-25E33F8D-5A64-497F-AC04-DC11D55F25A6Q35257612-9166CAA0-EF0A-4EF9-8E96-CDC2824FDA46Q35703517-82AB7C52-148B-413E-878E-A57435F37DBEQ35765263-8AC2266C-526D-4458-BE23-67641AF868B2Q35872124-C33567EC-9771-4F66-95B6-418C262134FCQ36208427-9020E6D8-6386-4D88-85B4-25EC0447B20FQ36329295-E656A14D-B848-475B-871D-E8BC345194BDQ36802786-1DDE1EDD-CF00-4E3B-82DB-DAD9351D335CQ36885279-97A29F2D-4AA5-4EA6-A599-143030AC59EAQ37408472-C9783019-5AA2-4344-A665-3BB6FA4F2C45Q38154624-B099F78F-F652-4D1F-9870-49204771A44AQ38198574-40408CA8-AA3C-45A5-B730-131845DFAF8DQ38248458-C4F300DE-FBD3-44FA-982D-4AD0E705F03FQ38386798-5DFFB30A-3CE8-4F20-879A-6D60E883E7DBQ38571581-4A9062DF-D125-4E5D-A89C-FDFFDF12FF02Q51761248-6A085DCD-9CB9-4846-BAFC-3C3C29E601F1Q55335157-6102504B-9CC5-421E-BA44-9020319EB776
P2860
Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose-response relationship for ...... with inhaled corticosteroids.
@en
Dose-response relationship for ...... with inhaled corticosteroids.
@nl
type
label
Dose-response relationship for ...... with inhaled corticosteroids.
@en
Dose-response relationship for ...... with inhaled corticosteroids.
@nl
prefLabel
Dose-response relationship for ...... with inhaled corticosteroids.
@en
Dose-response relationship for ...... with inhaled corticosteroids.
@nl
P2093
P1476
Dose-response relationship for ...... e with inhaled corticosteroids
@en
P2093
P304
P356
10.1111/J.1365-2222.2008.03029.X
P577
2008-06-03T00:00:00Z